<DOC>
	<DOCNO>NCT01727440</DOCNO>
	<brief_summary>The goal study enroll 250 participant join MURDOCK Study Horizon 1.5 ( Duke IRB Pro00011196 ) current prior diagnosis severe acne AND current prior treatment oral isotretinoin . All 250 participant answer 5-page questionnaire design collect information diagnosis severe acne response oral isotretinoin treatment . The aim identify genetic predictor severe acne vulgaris outcome oral isotretinoin treatment .</brief_summary>
	<brief_title>Identifying Genetic Predictors Severe Acne Vulgaris Outcome Oral Isotretinoin Treatment</brief_title>
	<detailed_description>Acne vulgaris under-studied common genetic disease tremendous economic consequence . Acne vulgaris one common skin condition treat doctor . It affect 40-50 million people USA , prevalence high 85 % ( recent study Iran 93 % ) teenager ; 18 % woman late onset ( &gt; 25yr ) acne vulgaris . Severe acne life-long psychosocial impact due significant scarring . Severe acne also associate severe systemic inflammatory disease fever , sterile osteomyelitis , inflammatory arthritis sign systemic inflammatory response . Some syndrome Mendelian form ( e.g . PAPA syndrome ) know genetic defect . Finally , data inconclusive , many suggestion diet exacerbate acne patient . The standard care treatment severe acne systemic retinoid therapy , , usually , always effective . Unfortunately , systemic retinoid treatment associate significant toxicity , include common cutaneous adverse effect ( dry lip , eye , skin fragility ) , less common laboratory abnormality elevate blood lipid , liver function abnormality , severe predictable teratogenicity . In addition , systemic therapy retinoids associate systemic disease clinical depression , suicide , inflammatory bowel disease , however mechanisms significance association determine . Given frequency severity severe acne , predictable severe toxicity systemic retinoid therapy , already demonstrate genetic association find Mendelian form severe acne , seem likely significant genetic risk factor may identify patient severe acne would promote new safer therapy , include dietary adjustment .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Diagnosed severe acne age &gt; 12 &lt; 18 , Completed least one course oral isotretinoin treatment ; OR start treatment discontinue prior completion due adverse side effect ( exception dry skin see `` exclusion criterion '' ) ; OR currently undergoing plan complete treatment Patients willing participate study Patients experience inflammatory bowel disease ( IBD ) prior oral isotretinoin treatment Patients complete oral isotretinoin treatment pregnancy , dry skin , reason adverse side effect list Patients willing provide blood sample Murdock Study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>severe acne</keyword>
	<keyword>severe acne vulgaris</keyword>
	<keyword>acne</keyword>
	<keyword>acne vulgaris</keyword>
	<keyword>isotretinoin</keyword>
	<keyword>Accutane</keyword>
	<keyword>Sortret</keyword>
	<keyword>Amnesteem</keyword>
	<keyword>Claravis</keyword>
	<keyword>Clarus</keyword>
	<keyword>Decutan</keyword>
	<keyword>Isotane</keyword>
	<keyword>Izotek</keyword>
	<keyword>Oratane</keyword>
	<keyword>Isotret</keyword>
	<keyword>Roaccutane</keyword>
</DOC>